On ECHEMI
Home > Drugs > CM1 gangliosidosis
CM1 gangliosidosis
CM1 gangliosidosis is a hereditary lysosomal disease caused by galactosidase deficiency. It is inherited in an autosomal recessive manner. The clinical features are progressive central nervous system disorders and skeletal abnormalities similar to mucopolysaccharidosis type I.
  • Site of disease:

    Skull bones
  • Infectious :

    Not contagious
  • Frequent population:

    The disease is more common in infants and adolescents, and also...
  • Related symptoms:

    Ataxia language disorder indifferent expression unsteady gait flat nose
  • Concurrent disease:

Related Drugs
Lysine Hydrochloride Glucose Injection
Indication: This product is a brain protective agent used to treat craniocerebral trauma, chronic cerebral ischemia and hypoxic diseases.
Manufacturer:

Sichuan Guorui Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.